The three previously utilized cell lines, along with Parks (melanoma–sensitive), 17CM98 (melanoma—moderate) and C2 (mast cell tumor–resistant), were assessed for AKT and ERK1/2 phosphorylation after 4 hours of exposure to VDX-111. The gene discussed is MAPK3; the disease is mast cell neoplasm.